Molecular mass and carbohydrate structure of prostate specific antigen: studies for establishment of an international PSA standard

Despite the widely accepted use of prostate specific antigen (PSA) as a marker of prostate cancer, this molecule has not yet been completely characterized. Past studies have well established, however, using both amino acid and cDNA sequencing techniques, that PSA contains 237 amino acids, with a mol...

Full description

Saved in:
Bibliographic Details
Published inThe Prostate Vol. 27; no. 4; p. 187
Main Authors Bélanger, A, van Halbeek, H, Graves, H C, Grandbois, K, Stamey, T A, Huang, L, Poppe, I, Labrie, F
Format Journal Article
LanguageEnglish
Published United States 01.10.1995
Subjects
Online AccessGet more information

Cover

Loading…
Abstract Despite the widely accepted use of prostate specific antigen (PSA) as a marker of prostate cancer, this molecule has not yet been completely characterized. Past studies have well established, however, using both amino acid and cDNA sequencing techniques, that PSA contains 237 amino acids, with a molecular mass of 26,079 Da for the peptide moiety of the molecule. The present study reports analysis of this protein by ion spray mass spectrometry (ISMS) and analysis of its carbohydrate moiety by NMR spectroscopy. The predominant PSA molecular species detected by ISMS was at relative molecular mass (M(r)) of 28,430, indicating that PSA contains a carbohydrate residue of M(r) 2,351, for a total percentage of carbohydrate of 8.3%. Analysis of PSA by SDS-PAGE, however, showed a M(r) of 32,000 to 33,000, suggesting an overestimation of the molecular weight by the latter technique. The complete primary structure of the PSA carbohydrate chain was determined by NMR spectroscopy in combination with carbohydrate composition analysis. The experimentally determined carbohydrate content of PSA confirms that only one N-glycosylation site is occupied in the protein. The proposed carbohydrate structure is a diantennary N-linked oligosaccharide of the N-acetyllactosamine type, with a sialic acid group at the end of each of the two branches. In addition, our data indicate that approximately 70% of the PSA molecules contain a fucose group in the core chitobiose moiety. The calculated molecular weight of this carbohydrate structure (M(r) 2,351.8) is in excellent agreement with the predicted molecular weight of the carbohydrate group, based on the M(r) 28,430 for PSA measured by ion spray mass spectrometry and M(r) 26,079 calculated from the consensus sequence for the peptide portion of the molecule. ISMS of PSA is thus proposed as a convenient and reliable method of quality control, an indispensible step towards international standardization of this very important tumor marker for detection and monitoring of prostatic diseases, especially prostate cancer.
AbstractList Despite the widely accepted use of prostate specific antigen (PSA) as a marker of prostate cancer, this molecule has not yet been completely characterized. Past studies have well established, however, using both amino acid and cDNA sequencing techniques, that PSA contains 237 amino acids, with a molecular mass of 26,079 Da for the peptide moiety of the molecule. The present study reports analysis of this protein by ion spray mass spectrometry (ISMS) and analysis of its carbohydrate moiety by NMR spectroscopy. The predominant PSA molecular species detected by ISMS was at relative molecular mass (M(r)) of 28,430, indicating that PSA contains a carbohydrate residue of M(r) 2,351, for a total percentage of carbohydrate of 8.3%. Analysis of PSA by SDS-PAGE, however, showed a M(r) of 32,000 to 33,000, suggesting an overestimation of the molecular weight by the latter technique. The complete primary structure of the PSA carbohydrate chain was determined by NMR spectroscopy in combination with carbohydrate composition analysis. The experimentally determined carbohydrate content of PSA confirms that only one N-glycosylation site is occupied in the protein. The proposed carbohydrate structure is a diantennary N-linked oligosaccharide of the N-acetyllactosamine type, with a sialic acid group at the end of each of the two branches. In addition, our data indicate that approximately 70% of the PSA molecules contain a fucose group in the core chitobiose moiety. The calculated molecular weight of this carbohydrate structure (M(r) 2,351.8) is in excellent agreement with the predicted molecular weight of the carbohydrate group, based on the M(r) 28,430 for PSA measured by ion spray mass spectrometry and M(r) 26,079 calculated from the consensus sequence for the peptide portion of the molecule. ISMS of PSA is thus proposed as a convenient and reliable method of quality control, an indispensible step towards international standardization of this very important tumor marker for detection and monitoring of prostatic diseases, especially prostate cancer.
Author Graves, H C
Grandbois, K
Labrie, F
Stamey, T A
Poppe, I
Bélanger, A
van Halbeek, H
Huang, L
Author_xml – sequence: 1
  givenname: A
  surname: Bélanger
  fullname: Bélanger, A
  organization: Laboratory of Molecular Endocrinology, Centre Hospitalier de l'Université Laval Research Center, Quebec, Canada
– sequence: 2
  givenname: H
  surname: van Halbeek
  fullname: van Halbeek, H
– sequence: 3
  givenname: H C
  surname: Graves
  fullname: Graves, H C
– sequence: 4
  givenname: K
  surname: Grandbois
  fullname: Grandbois, K
– sequence: 5
  givenname: T A
  surname: Stamey
  fullname: Stamey, T A
– sequence: 6
  givenname: L
  surname: Huang
  fullname: Huang, L
– sequence: 7
  givenname: I
  surname: Poppe
  fullname: Poppe, I
– sequence: 8
  givenname: F
  surname: Labrie
  fullname: Labrie, F
BackLink https://www.ncbi.nlm.nih.gov/pubmed/7479385$$D View this record in MEDLINE/PubMed
BookMark eNotkEtPwzAQhH0oKm3hzAnJfyDFj6R2uFUVFKQikIBztfGDGiVOZDuHXvnluNDTrlbf7Ghmjia-9wahG0qWlBB2N4Q-LlldEyZISfgEzU5bUVIuLtE8xm9CMkfYFE1FKWouqxn6eelbo8YWAu4gRgxeYwWh6Q9HHSAZHFMYVRqDwb3FJ4f0dx2MctapzCf3Zfx95kbtTMS2D9hkqGldPHTGp5MOPHY-meAhud5Di9_e11mRzSDoK3RhoY3m-jwX6PPx4WPzVOxet8-b9a5QpRC8kKysLNRGaslqWuYsnFaMW2krYZQUNTDLoOKMEyEbDVCvRO5hVVFaikpRtkC3_3-HsemM3g_BdRCO-3MX7Bd3ImK8
CitedBy_id crossref_primary_10_1038_srep22050
crossref_primary_10_1016_S0090_4295_96_00616_4
crossref_primary_10_1016_j_cca_2010_08_009
crossref_primary_10_1016_S0022_5347_01_64289_7
crossref_primary_10_1080_00032719_2014_928884
crossref_primary_10_1007_s10719_012_9428_8
crossref_primary_10_1016_j_cca_2024_119689
crossref_primary_10_1021_ja8028137
crossref_primary_10_1002_pros_2990270404
crossref_primary_10_1093_clinchem_46_4_474
crossref_primary_10_2478_v10011_008_0010_7
crossref_primary_10_1080_20014091084236
crossref_primary_10_1515_cclm_1997_35_9_693
crossref_primary_10_1080_00313029800169615
crossref_primary_10_1038_sj_pcan_4500965
crossref_primary_10_1007_s00216_008_2370_8
crossref_primary_10_3109_1354750X_2012_719035
crossref_primary_10_18632_oncotarget_10987
crossref_primary_10_1080_03008880510030941
crossref_primary_10_1093_clinchem_47_4_703
crossref_primary_10_1158_1541_7786_257_2_5
crossref_primary_10_1097_00005392_199705000_00062
crossref_primary_10_1016_0090_4295_95_80001_8
crossref_primary_10_1016_j_ijbiomac_2016_01_110
crossref_primary_10_3923_pjbs_2007_1496_1500
crossref_primary_10_18632_oncotarget_20299
crossref_primary_10_1515_CCLM_2008_129
crossref_primary_10_1016_S0923_2532_01_80043_0
crossref_primary_10_1002_pros_10085
crossref_primary_10_1016_j_neo_2017_07_008
crossref_primary_10_1016_S0923_2532_97_85337_9
crossref_primary_10_1016_j_jprot_2011_06_008
crossref_primary_10_1016_j_clinbiochem_2004_10_016
crossref_primary_10_2298_ABS0602077K
crossref_primary_10_1038_s41598_020_59622_y
crossref_primary_10_3389_fonc_2021_809170
crossref_primary_10_1016_S0094_0143_05_70370_0
crossref_primary_10_1021_ac203440c
crossref_primary_10_1093_glycob_cwm117
crossref_primary_10_1155_2013_923819
crossref_primary_10_1016_S0304_4165_00_00182_3
crossref_primary_10_1002_pmic_201500554
crossref_primary_10_1016_S0009_8981_96_06437_6
crossref_primary_10_1016_j_canep_2018_03_009
crossref_primary_10_1016_S0378_4347_01_00245_6
crossref_primary_10_1002_ijc_33517
crossref_primary_10_1093_glycob_cwp197
crossref_primary_10_1371_journal_pone_0065016
crossref_primary_10_1016_j_ab_2005_01_043
crossref_primary_10_1515_jomb_2017_0024
crossref_primary_10_1517_17530050903266830
crossref_primary_10_1002__SICI_1098_2825_1998_12_1_65__AID_JCLA11_3_0_CO_2_M
crossref_primary_10_2478_v10011_007_0041_5
crossref_primary_10_1016_S0009_9120_98_00055_1
crossref_primary_10_1080_07853890903156468
crossref_primary_10_1021_ac5024588
crossref_primary_10_1080_00032719_2016_1161047
crossref_primary_10_1080_10408369891234219
crossref_primary_10_1158_0008_5472_CAN_03_2025
crossref_primary_10_1515_CCLM_2008_145
crossref_primary_10_1111_j_1470_8744_1998_tb00502_x
crossref_primary_10_1016_S0022_5347_01_64851_1
crossref_primary_10_1002_pros_10256
crossref_primary_10_1039_C5AN00364D
crossref_primary_10_1021_pr400999y
crossref_primary_10_1021_a1960021u
crossref_primary_10_1016_j_clinbiochem_2004_09_022
crossref_primary_10_1016_S0090_4295_99_80076_4
crossref_primary_10_1021_ac503735e
crossref_primary_10_1093_clinchem_48_12_2187
crossref_primary_10_1007_s10735_005_5784_z
crossref_primary_10_1039_D3CB00010A
crossref_primary_10_1002__SICI_1097_0045_19980801_36_3_181__AID_PROS6_3_0_CO_2_K
crossref_primary_10_1006_prep_2000_1342
crossref_primary_10_1021_ac0709955
crossref_primary_10_1016_S0022_5347_01_64704_9
crossref_primary_10_1046_j_1432_1327_2001_02367_x
crossref_primary_10_1039_C4LC00464G
crossref_primary_10_1016_j_aca_2016_06_043
crossref_primary_10_1093_glycob_cwj042
crossref_primary_10_1002_pro_5560070205
crossref_primary_10_1093_clinchem_46_9_1310
crossref_primary_10_1021_ja037988s
crossref_primary_10_1016_j_bbrc_2014_04_107
crossref_primary_10_1016_S0094_0143_05_70372_4
crossref_primary_10_1177_1010428319827223
crossref_primary_10_1002_pros_20751
crossref_primary_10_1021_pr8007545
crossref_primary_10_1093_clinchem_45_4_486
crossref_primary_10_1007_s12038_008_0037_4
crossref_primary_10_1097_00005392_199710000_00085
crossref_primary_10_1016_S1479_666X_05_80048_4
crossref_primary_10_1021_pr8007539
crossref_primary_10_1093_clinchem_43_2_279
crossref_primary_10_1016_j_clinbiochem_2011_11_018
crossref_primary_10_1016_S0378_4347_99_00069_9
crossref_primary_10_3389_fchem_2019_00147
crossref_primary_10_1016_S0338_9898_99_80317_5
crossref_primary_10_1111_j_1464_410X_1997_tb00801_x
crossref_primary_10_1007_s00580_014_1910_1
crossref_primary_10_1016_j_cca_2012_06_007
crossref_primary_10_1515_CCLM_1998_120
crossref_primary_10_1002_pro_5560050505
crossref_primary_10_1016_j_tvjl_2008_07_012
crossref_primary_10_1002_pros_20089
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1002/pros.2990270403
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
ExternalDocumentID 7479385
Genre Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S
Journal Article
GrantInformation_xml – fundername: NCRR NIH HHS
  grantid: P41-RR-05351
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
123
1L6
1OB
1OC
1ZS
31~
33P
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CGR
CS3
CUY
CVF
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
ECM
EIF
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M6P
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
NPM
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
UB1
V2E
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WWO
WXI
WXSBR
XG1
XV2
ZGI
ZXP
ZZTAW
~IA
~WT
ID FETCH-LOGICAL-c4773-8245fa9e8d8291400131523f8f57ec879a2f2a5323078bdaa9677046511475c12
ISSN 0270-4137
IngestDate Sat Sep 28 08:36:05 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4773-8245fa9e8d8291400131523f8f57ec879a2f2a5323078bdaa9677046511475c12
PMID 7479385
ParticipantIDs pubmed_primary_7479385
PublicationCentury 1900
PublicationDate October 1995
PublicationDateYYYYMMDD 1995-10-01
PublicationDate_xml – month: 10
  year: 1995
  text: October 1995
PublicationDecade 1990
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Prostate
PublicationTitleAlternate Prostate
PublicationYear 1995
SSID ssj0010002
Score 1.881195
Snippet Despite the widely accepted use of prostate specific antigen (PSA) as a marker of prostate cancer, this molecule has not yet been completely characterized....
SourceID pubmed
SourceType Index Database
StartPage 187
SubjectTerms Amino Acid Sequence
Biomarkers, Tumor - analysis
Carbohydrate Sequence
Carbohydrates - analysis
Carbohydrates - chemistry
Electrophoresis, Polyacrylamide Gel
Humans
Magnetic Resonance Spectroscopy
Male
Mass Spectrometry
Molecular Sequence Data
Molecular Weight
Oligosaccharides - analysis
Oligosaccharides - chemistry
Prostate-Specific Antigen - analysis
Prostate-Specific Antigen - chemistry
Prostatic Neoplasms - chemistry
Prostatic Neoplasms - diagnosis
Reference Standards
Reproducibility of Results
Title Molecular mass and carbohydrate structure of prostate specific antigen: studies for establishment of an international PSA standard
URI https://www.ncbi.nlm.nih.gov/pubmed/7479385
Volume 27
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELW2VKBeEAUqPisfeqtSEseObW4VAlZUrSrRSr1VdmwLiTZbwXKAI_-B_8uM7WSzW4qgl2hlZ70bz_N4PJl5Q8iOUMGCDgwFrDZfcMabwgRYj0F47YxsSm0i2-dRMz3lH87E2WTyaxS19G1u99off8wruY1UoQ3kilmy_yHZYVBogM8gX7iChOH6TzI-7Gvb7l6CDZxS1MwXO_v03SEDxG4ih8VXBBjXjPkdsRVLzofI0zpHLk50CnxN4YSJABxui76pIU6gi6wSC8fh8cf9wQcxtm4Rc8f5Z4ZzfnoVfxHzi5ecp5g5NTUX1vvPS1kS77EiUoTXdOHDhcbO2VliRDhY-Cpi7ncf9darNCbLArZNOda_iRsg44yPlGmVtuJrSj6RxuKs7eFmCmPyyJMwH4n86jLKXKLjMNUE-mvnCud27lkja1Kh8jxCF1BfFqOMgazDo_R8USV7tfKXNsjdPNDKmSXaLicPyP186KD7CUGbZOK7h-TeYQ6reER-DkCiCCQKU03HQKIDkOgs0B5ItAcSzUB6TTOMKMCILsEIv2c6ugQjCjCiPYwek9N3b0_eTItcnKNouZR1oRgXwWivnGIaTunI2yRYHVQQ0rdKasMCM6LGRANlnTG6kTArDRj4XIq2YlvkTjfr_BNCK6FKXbdVWwXPwaK2VnAtXa1L50zZuKdkK83e-VViYDnP0_rspo7nZGMBvxdkPcCC9y_Bepzb7SjN35mDcEg
link.rule.ids 783
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Molecular+mass+and+carbohydrate+structure+of+prostate+specific+antigen%3A+studies+for+establishment+of+an+international+PSA+standard&rft.jtitle=The+Prostate&rft.au=B%C3%A9langer%2C+A&rft.au=van+Halbeek%2C+H&rft.au=Graves%2C+H+C&rft.au=Grandbois%2C+K&rft.date=1995-10-01&rft.issn=0270-4137&rft.volume=27&rft.issue=4&rft.spage=187&rft_id=info:doi/10.1002%2Fpros.2990270403&rft_id=info%3Apmid%2F7479385&rft_id=info%3Apmid%2F7479385&rft.externalDocID=7479385
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-4137&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-4137&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-4137&client=summon